Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on September 3, 2025
Keshuo Motor Highlights Expanding Role of 12V Worm Gear Motors in Key Industries
EIN Presswire
·
September 3, 2025
Company shares insights into future trends across automotive, healthcare, renewable energy, and automation sectors FL, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Keshuo Motor today released new insights into the expanding applications of 12V …
Alchem Laboratories and Applied Pharmaceutical Innovation Forge Strategic Alliance to Advance Antimicrobial Programs
EIN Presswire
·
September 3, 2025
Alchem Laboratories and Applied Pharmaceutical Innovation (API) Forge Strategic Alliance to Advance Antimicrobial and Essential Medicines Programs ALACHUA, FL, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Alchem Laboratories Corporation (“ …
Healogics® Raises Awareness of Peripheral Artery Disease (PAD) During September Awareness Month
EIN Presswire
·
September 3, 2025
JACKSONVILLE, FL, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Healogics®, the nation’s wound healing and hyperbaric oxygen therapy expert, is proud to recognize Peripheral Artery Disease (PAD) Awareness Month by urging patients and healthcare …
Thyroid Cancer Strikes Women 3x More Often — New #NeckCheck Challenge Aims to Change That
EIN Presswire
·
September 3, 2025
Florida surgeon launches nationwide campaign this Thyroid Cancer Awareness Month to make neck checks as routine as breast exams TAMPA , FL, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Women have been taught for decades how to perform breast …
Ascendo AI Demonstrates Agentic AI That Turns Knowledge Into Action at Field Service East, Orlando
EIN Presswire
·
September 3, 2025
Ascendo AI showcased its practical, agentic AI solutions for field service at Field Service East in Orlando ORLANDO, FL, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Ascendo AI showcased its practical, agentic AI solutions for field service at …
reLink Medical Expands Southeast Operations with Central Florida Distribution Center
EIN Presswire
·
September 3, 2025
reLink Medical opens Central Florida distribution center, expanding to 400K+ sq ft nationwide to deliver faster, sustainable equipment lifecycle solutions. LAKELAND, FL, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- reLink Medical, a national …
Molecular Assay Market to Grow at a CAGR of 7% During the Forecast Period (2025 – 2030): Wissen Research
GlobeNewswire
·
September 3, 2025
Sheridan, Sept. 03, 2025 (GLOBE NEWSWIRE) -- According to the latest market report published by Wissen Research, the global molecular assay market was valued at USD 16.4 billion in 2024. Furthermore, the market is expected to grow at a CAGR of 7% during …
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
GlobeNewswire
·
September 3, 2025
CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference …
UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
September 3, 2025
HIGH POINT, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being …
Sotera Health Announces Secondary Offering of Common Stock
GlobeNewswire
·
September 3, 2025
CLEVELAND, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 20,000,000 shares of its common stock, par value $0.01 per share. All 20,000,000 shares …
Artelo Biosciences Announces Proposed Underwritten Public Offering
GlobeNewswire
·
September 3, 2025
SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
Châtillon, France, September 3, 2025 DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage …
DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment
GlobeNewswire
·
September 3, 2025
Châtillon, France, le 3 septembre (22:30 CEST) 2025 DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP : 23306J309), une …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 3, 2025
SAN FRANCISCO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Pennant Announces Home Health Acquisition in Wyoming
GlobeNewswire
·
September 3, 2025
EAGLE, Idaho, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that effective September 1, 2025, it …
New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
GlobeNewswire
·
September 3, 2025
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies1 that …
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
GlobeNewswire
·
September 3, 2025
– Expands Avadel’s pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia – – Initial pharmacokinetic (PK) and comparative bioavailability study to initiate in fourth quarter 2025 …
Surrozen to Present at Upcoming Healthcare Investor Conference
GlobeNewswire
·
September 3, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …
Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2
GlobeNewswire
·
September 3, 2025
WARREN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the continuing need for SARS-CoV-2 treatments for individuals with weakened immune systems, who are at the highest risk of …
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
GlobeNewswire
·
September 3, 2025
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of Sleep Institute, a global clinical insights …